ARCHIVES

Get the latest industry insights.

Quality people. Great service. Responsive. Professional.

Tag: Amgen

Clinical Catch-Up: December 11-17

Amgen Reunites With Kyowa Kirin in $400 Million Atopic Dermatitis Deal

Via: https://www.biospace.com/article/amgen-reunites-with-kyowa-kirin-to-develop-atopic-dermatitis-drug-in-400-million-deal/?s=69 Amgen reunited with longtime developmental partner Japan’s Kyowa Kirin to develop a Phase III-ready atopic dermatitis treatment. This morning, California-based Amgen announced it will make a $400 million upfront payment to Kyowa Kirin to partner on the

Read More »
BioAge Picks Up Muscle-Aging Program From Amgen

BioAge Licenses Amgen Drug To Treat Muscle Aging

Via: https://www.fiercebiotech.com/biotech/bioage-picks-up-muscle-aging-program-from-amgen-bringing-pipeline-count-to-3 BioAge Labs is adding a third program to its pipeline. The new treatment, licensed from Amgen, is designed to combat muscle aging and could be useful in helping older people recover from surgery

Read More »